This facility is dedicated to manufacturing Cephalosporins and its combination products. It has the capacity to manufacture Solid and Liquid dosage forms of Cephalosporins. This facility houses a State-of-the-Art Pilot Plant for the manufacture of exhibit batches for Regulated Markets. This facility is approved by W.H.O. and currently caters to the needs of the Indian market.
FORM |
CAPACITY /MONTH |
APPROVALS |
---|---|---|
Oral Liquid –Bottles |
0.56 million |
WHO |
Solid Dosage –Tables |
51.0 million |
WHO |
Solid Dosage –Dry Syrup Powder (Bottles) |
0.625 million |
WHO |